Dimensional Fund Advisors’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Dimensional Fund Advisors’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-312,059	Closed	-$468K	–	3430
2018 Q1	$468K	Hold	312,059	–	–	﹤0.01%	3117
2017 Q4	$443K	Hold	312,059	–	–	﹤0.01%	3110
2017 Q3	$714K	Sell	312,059 -2,165	-0.7%	-$2.9K	﹤0.01%	3053
2017 Q2	$424K	Hold	314,224	–	–	﹤0.01%	3115
2017 Q1	$672K	Hold	314,224	–	–	﹤0.01%	3050
2016 Q4	$1.39M	Buy	314,224 +7,014	+2%	+$33.3K	﹤0.01%	2902
2016 Q3	$1.49M	Buy	307,210 +3,061	+1%	+$14K	﹤0.01%	2848
2016 Q2	$1M	Sell	304,149 -154,710	-34%	-$584K	﹤0.01%	2920
2016 Q1	$1.63M	Buy	+458,859	New	+$2.37M	﹤0.01%	2823

Other funds holding ARLZ

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

PCM

PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SCP

Silverleafe Capital Partners Germantown, Tennessee $367M AUM 37.49% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors's ARLZ Position: Q2 2018 in Review

Dimensional Fund Advisors sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2018, closing a stake of 312,059 shares — an estimated $468K sold.

Dimensional Fund Advisors first reported a position in ARLZ in Q1 2016 and held it in 9 quarters. The position peaked at $1.63M in Q1 2016. 48 funds tracked by Wall St. Rank hold ARLZ as of Q2 2018.

Dimensional Fund Advisors reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
Dimensional Fund Advisors sold 312,059 Aralez Pharmaceuticals Inc. shares in Q2 2018, an estimated $468K.
Dimensional Fund Advisors first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 9 quarters.
Dimensional Fund Advisors's Aralez Pharmaceuticals Inc. position peaked at $1.63M in Q1 2016.
48 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2018.

Based on Dimensional Fund Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.